A phase I study of IPH2101, a novel anti-inhibitory KIR monoclonal antibody, in patients with multiple myeloma. Background: Aminobisphosphonates (aBP) are standard of care for myeloma related bone ...
Please provide your email address to receive an email when new articles are posted on . Serum levels of sex steroids and bone metabolism markers align with skeletal development in boys during puberty, ...
SANTA FE, N.M. — In this video exclusive, Jacques P. Brown, MD, discusses clinical applications of bone turnover markers in managing osteoporosis. Brown is a rheumatologist, a clinical researcher at ...
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases Results from Studies of Other Investigational Merck Cancer ...
Youths with type 1 diabetes (T1D) show lower bone accrual than expected for their age, gender, pubertal stage, lean mass accrual, and growth, with greater urinary calcium excretion being associated ...
Patients with TSH-secreting adenomas have lower bone mineral density than euthyroid individuals, but surgery lowers levels of ...
Teeth naturally wear down over time, but scientists have found that they could signal certain cells to regrow bones, opening new avenues in stem cell research.
Tumor suppressor genes (TSG), treatment, and survival in de novo metastatic hormone-sensitive prostate cancer. Multivariate Cox proportional hazard model for PFS and OS. Bone Pain (yes vs No) 1.52, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results